Corbus Pharmaceuticals Holdings, Inc. Cash Equivalents, at Carrying Value
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Cash Equivalents, at Carrying Value of $20.50 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash Equivalents, at Carrying Value $20.50M.
- 2026-03-31: Cash Equivalents, at Carrying Value $23.80M.
- 2025-12-31: Cash Equivalents, at Carrying Value $27.14M.
- 2025-09-30: Cash Equivalents, at Carrying Value $25.48M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $20.50M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $23.80M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $27.14M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $25.48M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $17.75M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $16.55M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $12.15M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $15.89M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $19.18M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $9.15M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $9.70M 10-K · filed 2025-03-11 | $9.69M 10-K · filed 2024-03-12 |
| 2023-09-30 | $9.25M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $6.62M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $4.43M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $13.20M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $8.64M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $21.78M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $44.08M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $18.26M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $29.52M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $32.22M 10-Q · filed 2021-08-12 | |
| 2020-12-31 | $84.19M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |